Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL , Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB
Based on insights from medical professionals and research into GHK-Cus potential applications, those whod likely benefit most from products containing this peptide include: Regarding other potential applications mentioned earlier in this guide, like pain relief and anti-cancer activity, more human research is needed before definitively recommending it for those purposes
J.ShenY
Rethinking the protein RDA: why most people need twice the recommended amount for muscle health [A: 1:00:45, V: 1:06:40]
Targeted Pathway Support: Add-on therapies layered onto baseline therapy when symptoms suggest involvement of specific mediator pathways (e.g., leukotrienes or serotonin)
Generics developers watching this space should be mapping the prosecution history of each secondary filing to determine which, if any, were filed as CIPs off earlier applications because those are the patents with identifiable structural vulnerabilities that could support Paragraph IV certifications and accelerated market entry
